Tirilazad for aneurysmal subarachnoid haemorrhage (Q24243287)

https://api.crossref.org/works/10.1002%2F14651858.CD006778

Cerebral vasospasm following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Molecular keys to the problems of cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Management of aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Effects of the 21-aminosteroid U74006F on experimental head injury in mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778

7 January 2021